Can 3D-Printed insoles take the pressure off diabetic feet?
NCT ID NCT07781618
First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time
Summary
This study explores whether a portable 3D scanner can reliably measure foot shape and whether custom 3D-printed insoles can reduce pressure on the ball of the foot in healthy adults. Participants will have their feet scanned and tested with several insole designs to see which provides the best pressure relief. The goal is to improve the design of foot orthotics, which could one day help prevent foot ulcers in people with diabetes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Customized 3D-printed foot orthotics (insoles)
- What this could lead to
- If successful, this could lead to more precise, personalized insoles that better prevent foot ulcers in people with diabetes.
- What could go wrong
- This is a small, early study in healthy adults, so results may not apply to people with diabetes or other conditions. The insoles may not provide the expected pressure relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Aug 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Reliability study: The inclusion criteria: • Healthy population, age 18-65-year-old The exclusion criteria: * No injury of trauma of the lower limb in the past 6 months * No surgical procedures of the lower limbs or back in the past 6 months * Not pregnant at the time of testing * No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis) * No systemic or neurological disorder Interventional study The inclusion criteria: * Healthy population, age 18-65-year-old * Maximum weight of 90 kg * In-shoe M2 - M3 or central pattern bilateral or left/right The exclusion criteria: * No injury of trauma of the lower limb in the past 6 months * No surgical procedures of the lower limbs or back in the past 6 months * Not pregnant at the time of testing * No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis) * No systemic or neurological disorder * Work does not require wearing safety shoes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
KU Leuven Campus Bruges
Bruges, West-Flanders, 8200, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The effects of external nasal dilator strips on sleep and cardiovascular health
- A pharmacokinetic study of NTI164 in healthy adult volunteers
- Genetic determinants of Exercise-Induced muscle damage (POLYGENDOMUS) / déterminants génétiques des dommages musculaires induits par l'Exercice (POLYGENDOMUS)
- Can a simple injection timing reduce bleeding after skin cancer surgery?
- Can Land-Based teachings shape psychedelic therapy training?
- Can a new oral drug pass early safety tests?